# Merakris Therapeutics, LLC – FDA Inspection, Jun 30, 2022

Source: https://www.keypedia.com/records/fda_inspections/merakris-therapeutics-llc/f3b9ab0d-4f34-445d-863c-7f93f2a946fe
Source feed: FDA_Inspections

> FDA inspection 1177756 of Merakris Therapeutics, LLC, June 30, 2022. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1177756
- Company Name: Merakris Therapeutics, LLC
- Inspection Date: 2022-06-30
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1238909 - 2024-05-15

Company: https://www.keypedia.com/companies/merakris-therapeutics-llc/b3540a6f-f3bd-466a-9c59-716751c73d07

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d